The trends driving ELRIG Drug Discovery 2022
Drug Discovery World
OCTOBER 4, 2022
Orbit hopes the funds will further validate the microfluidic components of its peptide discovery platform, resulting in a next-generation microfluidic-based functional screen capable of interrogating millions of peptides in cell-based assays. . This year has seen some major deals announced by big pharma companies.
130 
Let's personalize your content